The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
biotie therapies corporation | 246 |
h. lundbeck | 46 |
synosia therapeutics | 38 |
wyeth | 20 |
elbion | 15 |
kiss, lorand | 10 |
faron pharmaceuticals | 5 |
inalco | 1 |
ehlbion | 1 |
biotie therapies ag of | 1 |
biotie therapies corporation | 20 |
synosia therapeutics | 12 |
wyeth | 7 |
elbion | 6 |
ehlbion | 1 |
faron pharmaceuticals | 1 |
biotie therapies corporation | 28 |
kiss, lorand | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
nalmefene hydrochloride dihydrate | 53 | 2008 |
use of vap-1 inhibitors for treating fibrotic conditions | 40 | 2009 |
novel fully human anti-vap-1 monoclonal antibodies | 34 | 2007 |
methods for treating dependence | 27 | 2007 |
new pyridazinone and pyridone compounds | 24 | 2011 |
a2a antagonists as cognition and motor function enhancers | 18 | 2010 |
aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10 | 15 | 2007 |
4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol… 🛈 | 14 | 2007 |
benzothiazole derivatives | 14 | 2009 |
treatment of post-traumatic stress disorder | 13 | 2007 |